kabutan

AFC-HD AMS Life Science, 0.1％ Increase in Ordinary Profit, Update Record High for Second Consecutive Term, Dividend Raised by 2 Yen

Wed Oct 15, 2025 3:40 pm JST Earnings

2927 AFC-HD AMS Life Science Co.,Ltd. 【J-GAAP】

Earnings Report

AFC-HD AMS Life Science Co.,Ltd. <2927> [TSE Std] announced its financial results after the market closed on October 15th (15:40). The consolidated ordinary profit for the fiscal year ended August 2025 increased by 27.2% from the previous period to 2.44 billion yen. For the fiscal year ending August 2026, the consolidated ordinary profit is nearly flat with a slight increase of 0.1% to 2.44 billion yen, marking the second consecutive term of record-high profits. This will be the sixth consecutive term of revenue and the fourth consecutive term of profit growth.

At the same time, the company has decided to increase the dividend this fiscal year to 36 yen, an increase of 2 yen from the previous fiscal year.

In the most recent three-month period, from June to August (4Q), the consolidated ordinary profit increased 41.3% from the same period last year, reaching 0.57 billion yen. The operating profit margin improved from 5.4% in the same period last year to 7.0%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Aug, 2023 25,579 1,636 1,654 1,102 78.5 27.50 Oct 13, 2023 J-GAAP
Aug, 2024 30,185 1,916 1,921 1,252 89.2 30 Oct 15, 2024 J-GAAP
Aug, 2025 32,655 2,409 2,443 1,448 103.0 34 Oct 15, 2025 J-GAAP
YoY +8.2% +25.7% +27.2% +15.7% +15.4%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Aug, 2025 Guidance 32,655 2,406 2,441 1,428 101.5 34 Oct 3, 2025 J-GAAP
Aug, 2025 Results 32,655 2,409 2,443 1,448 103.0 34 Oct 15, 2025 J-GAAP
Revision Rate 0.0% +0.1% +0.1% +1.4% +1.4%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep - Feb, 2024 16,614 1,294 1,332 881 62.7 16 Apr 14, 2025 J-GAAP
Sep - Feb, 2025 Guidance 16,725 1,297 1,334 883 62.6 18 Oct 15, 2025 J-GAAP
YoY +0.7% +0.2% +0.2% +0.2% -0.1%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Aug, 2024 30,185 1,916 1,921 1,252 89.2 30 Oct 15, 2024 J-GAAP
Aug, 2025 32,655 2,409 2,443 1,448 103.0 34 Oct 15, 2025 J-GAAP
Aug, 2026 Guidance 34,137 2,545 2,445 1,462 103.6 36 Oct 15, 2025 J-GAAP
YoY +4.5% +5.6% +0.1% +1.0% +0.6%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jun - Aug, 2024 7,841 421 407 330 23.5 5.4 Oct 15, 2024 J-GAAP
Sep - Nov, 2024 8,189 650 704 460 32.7 7.9 Jan 14, 2025 J-GAAP
Dec - Feb, 2024 8,425 644 628 421 29.9 7.6 Apr 14, 2025 J-GAAP
Mar - May, 2025 8,123 559 536 531 37.8 6.9 Jul 10, 2025 J-GAAP
Jun - Aug, 2025 7,918 556 575 36 2.6 7.0 Oct 15, 2025 J-GAAP
YoY +1.0% +32.1% +41.3% -89.1% -89.1%

Related Articles